
For the long protocol of down regulation in in vitro fertilization (IVF) cycles, are depot and daily gonadotropin-releasing hormone agonists (GnRHa) equally effective?

For the long protocol of down regulation in in vitro fertilization (IVF) cycles, are depot and daily gonadotropin-releasing hormone agonists (GnRHa) equally effective?

An independent panel convened by the National Institutes of Health has concluded that there is insufficient evidence to adopt a 1-step approach to the diagnosis of gestational diabetes mellitus (GDM).

The use of robotically assisted hysterectomy for women with benign gynecological disease offers little short-term benefit and has significantly greater costs than laparoscopic hysterectomy, according to the results of a large US cohort study.

Hysteroscopic removal of polyps in women with unexplained infertility may increase their chances of becoming pregnant, concludes an intervention review conducted by the Cochrane Menstrual Disorders and Subfertility Group.

In patients with gestational diabetes mellitus, metformin is an effective alternative to insulin, according to the findings of a recent single-center randomized controlled study.

Patients with stage IVB, recurrent, or persistent cervical cancer that was not cured with standard treatment who were given the angiogenesis inhibitor bevacizumab lived 3.7 months longer than patients who did not receive the drug, but adverse events increased.

A study assessing the effectiveness of acetaminophen for neonatal pain relief found that use of acetaminophen shortly after birth may aggravate a subsequent stress response.

There is no evidence that plastic adhesive surgical drapes reduce surgical site infection rates, and some evidence that these drapes may increase infection rates, according to a third update of an intervention review and analysis conducted by the Cochrane Wounds Group.

Vitamin D deficiencies are common in women with primary ovarian insufficiency (POI), and serum levels of zinc, copper, and vitamin D appear to correlate with hormonal status, concluded a recent cross-sectional, case-control study.

Intramuscular anti-D and intravenous anti-D administered in the 28th week of pregnancy are equally effective for the prevention of Rhesus alloimmunization during pregnancy, according to a new intervention review conducted by the Cochrane Pregnancy and Childbirth Group.

In clinical trials, 12 weeks of desvenlafaxine effectively treated moderate to severe hot flashes in postmenopausal women, and the benefit remained after 1 year of maintenance treatment.

Serial compression ultrasonographic testing in conjunction with Doppler imaging can reliably rule out blood clots in the legs of women who are pregnant, according to new study findings.

Immediate start of hormonal contraception may reduce unintended pregnancies and increase method continuation, but the evidence is limited, according to the findings of an intervention review conducted by the Cochrane Fertility Regulation Group.

The current genitourinary fistula classification systems have poor to fair prognostic value, as does an empirically derived scoring system that predicts fistula closure 3 months after surgery, according to the findings of a new prospective cohort study.

Monitoring uterine contractions with internal tocodynamometry (IT) versus external tocodynamometry (ET) results in similar maternal and neonatal outcomes in women whose labor is induced or augmented with oxytocin.

The use of APTIMA human papillomavirus (AHPV) assay for the detection of high-risk human papillomavirus E6/E7 oncogenic messenger RNA is an effective triage method for colposcopy referral in women with atypical squamous cells of undetermined significance cytology (ASC-US).

Women who have migraine with aura, especially those who take combined hormonal contraceptives (CHCs) have an increased risk for cardiovascular or thrombotic events.

On January 18, 2013, the FDA announced its approval of onabotulinumtoxinA (Botox) for the treatment of overactive bladder in adults who cannot use or who do not respond adequately to anticholinergic medications.

Patients with pelvic girdle pain during pregnancy who had a cesarean section were more likely to experience persistent pain 6 months after delivery than patients who delivered vaginally, according to a new follow-up study from the Norwegian Institute of Public Health.

New drugs, new research, new guidelines… there’s a lot for ob/gyns to look forward to in the coming year. Here, the leaders of seven ob/gyn societies share the most interesting, important, exciting things on their radar for 2013.

From ASRM’s removal of the ‘experimental’ label from the procedure of oocyte cryopreservation, to discoveries into the complex genetic processes involved in ovarian cancer, 2012 was another important year in ob/gyn research. Here, the leaders of seven major ob/gyn societies reflect on the most exciting research of the last year.

An independent panel convened by the NIH has concluded that the name “polycystic ovary syndrome (PCOS)” causes confusion and is a barrier to progress in the realms of both research and effective patient care.

Continuous infusion of the NSAID ketorolac, a powerful nonopioid analgesic, is a safe therapeutic option for the management of postoperative pain, concludes a double-blind randomized controlled trial.

In lower-segment cesarean deliveries, blunt dissection of the uterine incision is associated with less blood loss than sharp dissection, according to the findings of a recent systematic review and meta-analysis.

The symptoms of overactive bladder syndrome were most improved when patients used anticholinergic drugs either alone or in combination with bladder training exercises, according to the results of an intervention review and meta-analysis conducted by the Cochrane Incontinence Group.

Both vaginal progesterone and cervical cerclage can effectively prevent preterm birth in women at risk for spontaneous preterm birth, according to the results of an adjusted indirect meta-analysis of randomized controlled trials.

Certain herbal and complementary medicines may be a valuable treatment option for women with postmenopausal symptoms, according to a new review outlining the advantages and limitations of the available treatments of postmenopausal symptoms.

Women should wait 12 to 18 months after weight-loss surgery before trying to become pregnant, according to an evidence-based literature review.

Nurse-delivered interventions that combined psychoeducation with supportive attention may help improve mood in patients in whom cancer has been newly diagnosed.

After a cesarean delivery, closing the incision with staples, compared with sutures, is associated with significantly more composite wound morbidity, according to the results of a new randomized controlled trial.